Bollenbacher Michael OD Boulder, CO - 80302

Bollenbacher Michael OD is categorized under Physicians Offices in Boulder, CO and active since 2007.

Bollenbacher Michael OD was established in 2007, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Physicians Offices business, which does work in the B2C market, and is classified as a Physicians Offices, under code number 6213200 by the NAICS.

If you are seeking more information, feel free to contact Michael Bollenbacher at the company’s single location by writing to 2525 Arapahoe Avenue Unit E23, Boulder, Colorado CO 80302 or by phoning (303) 444-1405. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Bollenbacher Michael OD
Contact Person: Michael Bollenbacher
Address: 2525 Arapahoe Avenue Unit E23, Boulder, Colorado 80302
Phone Number: (303) 444-1405
Website Address: drbollenbacher.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Physicians Offices
SIC Code: 8011
NAICS Code: 6213200
Share This Business:

Bollenbacher Michael OD was started in 2007 to provide professional Physicians Offices under the SIC code 8011 and NAICS code 6213200. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Michael Bollenbacher for inquiries that concern Bollenbacher Michael OD by calling the company number (303) 444-1405, as your correspondence is most welcome. Additionally, the physical location of the single location of Bollenbacher Michael OD can be found at the coordinates 40.014711,-105.261633 as well as the street address 2525 Arapahoe Avenue Unit E23 in Boulder, Colorado 80302.

For its online presence, you may visit Bollenbacher Michael OD’s website at drbollenbacher.com and engage with its social media outlets through on Twitter and on Facebook.